| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-10 | 2025-02-28 | 2021-03-30 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 142.6 | 76.24 | 0.935 |
| Research & Development | 107.6 | 55.82 | 0 |
| Selling, General and Administrative | 35.01 | 20.42 | 0.935 |
| Other Operating Expenses | 0 | 0 | -0 |
| Operating Income | -142.6 | -76.24 | -0.935 |
| Net Non-Operating Interest | 6.45 | 5.06 | 0.383 |
| Interest Income | 6.45 | 5.06 | 0.383 |
| Interest Expense | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 134.7 | 71.18 | -0 |
| Income Before Tax | -1.38 | 0 | -0.552 |
| Income Tax Expense | 0.038 | 0 | 0.038 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0.001 |
| Net Income | -1.42 | 0 | -0.591 |
| Depreciation and Amortization | -3.09 | 0 | 0.383 |
| EBITDA | -145.7 | -76.24 | -0.552 |
| Earnings Per Share (EPS) | -9.73 | -4.89 | -0.047 |
| Diluted Earnings Per Share | -9.28 | -4.89 | -0.047 |
| Weighted Average Shares Outstanding | 15,022 | 14,585 | 12.5 |
| Diluted Weighted Average Shares Outstanding | 15,334 | 14.58 | 12.5 |
